Willow vs Oak Longevity: Oral GLP-1, Pricing, Support
Quick verdict: Willow emphasizes a structured oral GLP-1 program with progress tracking and follow-up support, while Oak Longevity emphasizes lower prices and simple, no-subscription pricing. For most cost-conscious patients Oak is the lower-cost option; for users who want structured digital follow-up Willow focuses on ongoing behavioral support.
Explore Willow’s structured program
Willow vs Oak Longevity: core positioning and approach
Willow positions its offering as a telehealth-first weight management program that pairs oral GLP-1 with wellness tracking and follow-up consultations. Oak Longevity positions itself as a telehealth platform selling compounded GLP-1 medications at lower prices, with semaglutide from $133/month and tirzepatide from $199/month and free health coaching included.
Key differences at a glance
This comparison focuses on the most distinctive supported differences: pricing model and cost, follow-up and tracking, medication format and regulatory notes, access and clinical review workflow, and shipping and extras.
| Criteria | Willow | Oak Longevity |
|---|---|---|
| Starting price | $299 starting price | Semaglutide from $133/mo; tirzepatide from $199/mo |
| Pricing model | Higher monthly entry pricing for some plans | One flat price for all dosages; no subscriptions |
| Follow-up and tracking | Progress tracking tools and follow-up consultations | Free health coaching included |
| Medication format and regulatory note | Oral GLP-1; compounded medications when offered are not FDA-approved | Compounded semaglutide and tirzepatide; compounded medications are not FDA-approved |
| Clinical review workflow | Telehealth-first with licensed clinicians determining appropriateness | Asynchronous online questionnaire; board-certified physicians review each case |
| Shipping and extras | Not verified on the captured page | Free shipping with tracking; same-day approval available for qualifying patients |
Pricing model and who pays less
Oak Longevity is documented as offering semaglutide from $133/month and tirzepatide from $199/month, with one flat price for all dosages and no subscriptions or membership fees. Willow shows a starting price of $299 and is described as having higher monthly entry pricing for some plans. If cost per month is the primary concern, Oak is the lower-cost option based on the supplied starting prices.
Follow-up, coaching, and program structure
Willow frames its service as a structured weight management journey that emphasizes progress tracking and follow-up consultations to convert medication effects into long-term outcomes. Oak Longevity includes free health coaching with every plan and highlights that no video call is required and the clinical review is asynchronous. The distinction is Willow positions itself around structured behavioral scaffolding while Oak includes coaching alongside a lower-cost medication model.
Learn about Willow follow-up support
Medication type, safety note, and clinical access
Both providers reference compounded medications in their materials. The supplied evidence states explicitly that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Willow notes that treatment is available only when a licensed clinician determines it is medically appropriate. Oak likewise requires clinician review, with board-certified physicians in your state reviewing every case and patients completing an online questionnaire.
Shipping, approvals, and practical differences
Oak Longevity documents free shipping with tracking and same-day approval available for qualifying patients, and states three-month prescriptions are billed upfront with no subscriptions. Willow’s captured page did not verify shipping, fees, membership, or cancellation details in the evidence provided.
Conclusion and recommendation
Willow vs Oak Longevity centers on tradeoffs between structured digital follow-up and lower price with minimal workflow friction. Both require clinician review and note that compounded medications are not FDA-approved.
Choose Willow if you want a telehealth-first oral GLP-1 program that emphasizes progress tracking and follow-up consultations. Choose Oak Longevity if you prioritize lower starting prices, one flat price for all dosages, and free shipping with coaching.